NEW YORK (AP) — An Ivy League-educated ex-portfolio manager convicted of enabling his firm to earn more than a quarter-billion dollars through insider trading on a promising Alzheimer’s drug trial was sentenced Monday to nine years in prison by a judge who said the “staggering” fraud deserved lengthy incarceration.
Mathew Martoma, his face drawn, left Manhattan federal court holding his wife’s hand after Judge Paul Gardephe ordered him to report to prison in November following his February conviction for conspiracy and securities fraud.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.